Morphometric and morphologic evaluations in stage III non‐small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells
暂无分享,去创建一个
J F Silverman | J. Silverman | Tung‐Kwang Lee | C. Scarantino | Yue Chen | Ronnie D. Horner | Claire Jenny | T K Lee | R D Horner | Y H Chen | C Jenny | C W Scarantino
[1] D. Cox. Regression Models and Life-Tables , 1972 .
[2] J. Gluckman,et al. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx , 1984, Cancer.
[3] D. Page,et al. Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population , 1987, Journal of surgical oncology.
[4] W. Weiss. The mitotic index in bronchogenic carcinoma. , 1971, The American review of respiratory disease.
[5] H. Hiratsuka,et al. Lymphocyte subpopulations and T-cell subsets in human oral cancer tissues: immunohistologic analysis by monoclonal antibodies. , 1984, American journal of clinical pathology.
[6] M. Moore,et al. Human tumor-infiltrating lymphocytes: a marker of host response. , 1985, Seminars in hematology.
[7] T. Flotte,et al. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. , 1982, American journal of clinical pathology.
[8] H. Ioachim. The stromal reaction of tumors: an expression of immune surveillance. , 1976, Journal of the National Cancer Institute.
[9] J. Parker,et al. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer , 1978, Cancer.
[10] J. Jacobs,et al. The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin‐containing combination chemotherapy , 1986, Cancer.
[11] K. Kayser,et al. Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients , 1987, Cancer.
[12] M. Wernicke,et al. Host defense factors, tumor aggressiveness, and prognosis associated with carcinomas of the breast. , 1984, Human pathology.
[13] J. Baak,et al. The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer , 1985, Histopathology.
[14] V. Roggli,et al. Lung cancer heterogeneity. Prognostic implications , 1987, Cancer.
[15] P. Maldague,et al. Prognostic implications of mean nuclear diameter in breast cancer. , 1980, British Journal of Cancer.
[16] K E Stanley,et al. Prognostic factors for survival in patients with inoperable lung cancer. , 1980, Journal of the National Cancer Institute.
[17] P. Schofield,et al. Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. , 1981, British Journal of Cancer.
[18] Crissman Jd. Tumor-host interactions as prognostic factors in the histologic assessment of carcinomas. , 1986 .
[19] A. House,et al. Colonic carcinoma. A quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis , 1978, Cancer.
[20] J. Underwood. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. , 1974, British Journal of Cancer.
[21] M. Bond,et al. The significance of nuclear diameter in the biologic behavior of thyroid carcinomas: a retrospective study of 127 cases. , 1987, Human pathology.
[22] M. Moore,et al. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours , 1979, International journal of cancer.
[23] G W Moore,et al. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung , 1984, The American journal of surgical pathology.
[24] M. Bond,et al. The significance of mitotic rate: a retrospective study of 127 thyroid carcinomas. , 1985, Human pathology.
[25] P. Davaris,et al. Prognostic significance of histologic host response in cancer of the large bowel , 1981, Cancer.
[26] R. Zaino,et al. Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis. , 1982, The Annals of thoracic surgery.
[27] J. Svennevig. IN SITU IDENTIFICATION OF INFLAMMATORY CELLS IN MALIGNANT, NON‐LYMPHOID HUMAN TUMOURS , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[28] R. James,et al. MITOTIC INDEX IN CARCINOMA OF THE LUNG , 1979, The Lancet.
[29] C. Miracco,et al. Bronchogenic carcinoma: Survival after surgical treatment according to stage, histologic type and immunomorphologic changes in regional lymph nodes , 1981, Cancer.
[30] M. di Paola,et al. Histology of bronchial carcinoma and regional lymph nodes as putative immune response of the host to the tumor. , 1977, The Journal of thoracic and cardiovascular surgery.
[31] R. Giorno. Mononuclear cells in malignant and benign human breast tissue. , 1983, Archives of pathology & laboratory medicine.
[32] C. Scarantino,et al. Results of Clinical Trials and Basis for Future Therapeutics , 1985 .
[33] J. Crissman,et al. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. , 1987, The American journal of pathology.
[34] Douglas A. Wolfe,et al. Nonparametric Statistical Methods , 1973 .
[35] Y. Shimosato,et al. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers. , 1983, Cancer research.
[36] J. Baak,et al. The value of morphometry to classic prognosticators in breast cancer , 1985, Cancer.
[37] T. Flotte,et al. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate. , 1987, Human pathology.